Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Par Pulls Out Of Advancis Partnership

Aug 03 2005

• By Sue Sutter

Related Content

Par's Megace ES Clears FDA; Company Will Target Generic Megestrol Users

Jul 06 2005

Par Expects Megace ES Label To Reflect Dosing, Bioavailability Advantages

Apr 28 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window